Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 102 participants.

Also called NCT03728985

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03728985
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03728985. Non-randomized; no masking; primary purpose treatment. Start 2019-06-17 (actual); primary completion 2023-01-04 (actual). Results posted on 2024-08-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Acronym
TAMBE
Condition
Thoracoabdominal Aortic Aneurysm
Intervention (Device)
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct03728985
Content hash
289268dbf42c3ec1cf86c48e960c4a0da3e38143e2b9042498985ab74ceb6547